Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
A major cause of the paucity of new starting points for drug discovery is the lack of interaction between academia and industry. Much of the global resource in biology is present in universities, whereas the focus of medicinal chemistry is still largely within industry. Open source drug discovery, w...
Main Authors: | Van Voorhis, W, Adams, J, Adelfio, R, Baker, S, Sinden, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2016
|
Similar Items
-
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
by: Van Voorhis, Wesley C., et al.
Published: (2017) -
Anticancer Activities of Mushrooms: A Neglected Source for Drug Discovery
by: Sujogya Kumar Panda, et al.
Published: (2022-01-01) -
Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery
by: Martina Maccesi, et al.
Published: (2019-10-01) -
Neglected diseases and drug discovery /
by: Palmer, Mike, et al.
Published: (c201) -
Repurposing the open access malaria box reveals compounds with activity against Tritrichomonas foetus trophozoites
by: Katy A. Martin, et al.
Published: (2020-08-01)